Findings
The CardiacSense PPG device can reliably detect heart rate in various situations, but noise suppression during activity remains a challenge.
The study did not directly address the device’s ability to detect atrial fibrillation in ambulatory patients, indicating a gap in current research.
Further studies are needed to confirm the device’s effectiveness in detecting AF during ambulatory conditions.

Recommendations
Improve noise suppression technology to enhance the device’s accuracy during motion.
Conduct further studies to validate the device’s ability to detect atrial fibrillation in ambulatory patients.
Continue research to address the limitations identified in the current study.

Regulatory Considerations
Adherence to FDA guidance for new medical device applications is crucial.
Ensure compliance with regulatory standards for digital health technologies.